Day: June 27, 2023
MDNA11 demonstrates durable single-agent activity in forth-line metastatic pancreatic cancer patient with a partial response continuing for over 40 weeks and stable disease for over 70 weeks as a third-line treatment in a patient with metastatic melanomaMDNA11 clinical update is anticipated during calendar Q3 2023, for all dose escalation patients including high dose cohorts five and six including outcomes from safety review committee; conference call to be held in conjunction with clinical updatePhase 2 ABILITY study’s single agent dose expansion portion is expected to commence in calendar Q3 2023$33.6 million in cash and cash equivalents as of March 31, 2023 expected to provide runway through key milestones of the ABILITY study and through calendar Q3 2024TORONTO and HOUSTON, June 27, 2023 (GLOBE NEWSWIRE) — Medicenna...
Aemetis RNG Production Exceeds Plan by 20% During Q2 2023
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Seven dairy digesters, 40-mile biogas pipeline, centralized Biogas-to-RNG facility, and utility pipeline interconnection are operating 24×7 to deliver RNG for the displacement of petroleum-based fuels in trucks, buses, and cars
CUPERTINO, CA, June 27, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas (RNG) and renewable fuels company focused on negative carbon intensity products, announced today that its Aemetis Biogas subsidiary is operating the Central Dairy Project production facilities 24 hours per day, seven days per week, and exceeded the RNG production plan by approximately 20% during Q2 2023.
“Production rates at our dairy digesters are notably higher than our original projections,” stated Andy Foster, President of Aemetis Biogas. “Our biogas pipeline, biogas-to-RNG production...
LiveOne Reports Fiscal Year 2023 Revenue of $99.6M and Record Adjusted EBITDA* of $10.9M, a $24.4M Improvement Year-Over-Year
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Audio Division Revenue of $86.8M and Adjusted EBITDA* of $18.2M for Fiscal Year 2023, a 289% Increase Year-Over-Year
Raises Fiscal Year 2024 Revenue Guidance for Audio Division to $100M – to $110M and Adjusted EBITDA* to $18M – $21M
Audio Division Q4 Fiscal 2023 Revenue of $22.9M and Adjusted EBITDA* of $4.5M versus $2.4M in Q4 Fiscal 2022, an 89% Increase
Raises Company Guidance for Fiscal Year 2024 Revenue of $122M – $130M and Adjusted EBITDA* of $12M – $16M
LiveOne’s PodcastOne Expects to Deliver a Record-Breaking Q1 Fiscal 2024 of Over $10.5M in Revenue and Fiscal Year 2024 Revenue Between $40M – $45M
PodcastOne’s S-1 Registration Statement Declared Effective by the SEC
Repaid $3 million of PodcastOne Debt
Increased PodcastOne Special Dividend from 12% to ~ 19%
Record Growth of 612K+ New Paid Members – a...
Talenom acquires a Spanish accounting company Aditio Gestion
Written by Customer Service on . Posted in Public Companies.
Talenom Plc, Press release 27 June 2023 at 15:00 EEST
Talenom acquires a Spanish accounting company Aditio Gestion
Talenom Plc has agreed to acquire the entire share capital of Aditio Gestion S.l., an accounting company operating in Asturias and Madrid, Spain. The acquired company will be transferred to Talenom on 27 June 2023. Aditio Gestion provides accounting, tax and other advisory services mainly to SMEs in the region.
The net sales transferred to Talenom from the acquired company is some EUR 1.7 million annually. The company employs a total of 30 persons who will continue to work for Talenom. In the short term, the acquisition will not have any significant impact on Talenom’s financial position or future outlook.
Talenom combines software development with expertise in the accounting industry in a unique way. The aim of the company...
Predictive Oncology Appoints Biopharmaceutical Finance Veteran Mr. Andrew Einhorn to its Business Advisory Board
Written by Customer Service on . Posted in Public Companies.
EAGAN, Minn., June 27, 2023 (GLOBE NEWSWIRE) — Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and enable drug development, today announced the appointment of biopharmaceutical finance veteran Mr. Andrew Einhorn to its Business Advisory Board.
“Andrew Einhorn brings a wealth of senior financial leadership experience in the biopharmaceutical industry to our Business Advisory Board, and I am very pleased that he has agreed to join,” said Raymond F. Vennare, Chief Executive Officer of Predictive Oncology. “As our momentum continues to accelerate,...
Gentex Foundation Awards First Recipients of College Scholarship to Support Women in Stem
Written by Customer Service on . Posted in Public Companies.
Gentex Scholarship Winners
The Gentex Foundation has named Madelyn Rynsburger and Paige Lampen the first recipients of the Amanda Clark Scholarship, a new program announced in October of last year, to support female high school seniors pursuing a degree in science, technology, engineering, or math (STEM). Left to right: Ally Clark (Amanda Clark’s Daughter), Paige Lampen (Scholarship Winner), Madelyn Rynsburger (Scholarship Winner), Seth Bushouse (Gentex Sr. Dir. Human Resources)ZEELAND, Mich., June 27, 2023 (GLOBE NEWSWIRE) — The Gentex Foundation has selected the first recipients of the Amanda Clark Scholarship, a new program announced in October of last year, to support female high school seniors pursuing a degree in science, technology, engineering, or math (STEM).
The scholarship committee selected two winners this year:...
Actelis Selected to Upgrade HVAC Networking Solution for United States Military Under Base Modernization Initiative
Written by Customer Service on . Posted in Public Companies.
International Engineering Firm, Jacobs, Partners with Actelis Utilizing its Cyber-Hardened, Rapid Deployment Hybrid Fiber-Copper Networking Solution To Quickly Complete Upgrade Project
FREMONT, Calif., June 27, 2023 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”) a market leader in cyber-hardened, rapid deployment networking solutions for wide area IoT applications, today announced that its hybrid fiber-copper networking solution has been selected for installation by the United States military to enable and extend connectivity for Heating, Ventilation, and Air Conditioning (HVAC) system monitoring and control. The project is being deployed in conjunction with Actelis integration partner, Jacobs, and will replace the client’s existing 3rd party connectivity solution.
HVAC monitoring systems include...
TAC-STIM™ Non-Invasive Vagal Nerve Stimulation Selected for Inclusion in the Air Force Research Laboratories Real-Time Assessing and Augmenting Cognitive Performance in Extreme Environments Project
Written by Customer Service on . Posted in Public Companies.
ROCKAWAY, N.J., June 27, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that its TAC-STIM non-invasive vagus nerve stimulation (“nVNS”) Human Performance product, has been selected to be a part of the Air Force Research Laboratories (AFRL) Real-Time Assessing and Augmenting Cognitive Performance in Extreme Environments (A2PEX) Grant Program. A2PEX is a five-year project led by the Florida Institute for Human and Machine Cognition (IHMC) that includes internationally-recognized leaders in wearable technologies from industry and academia.
The goal of A2PEX is to build a wearable system to sense, assess and augment cognitive performance in operational environments. Sensors developed by A2PEX partners will develop electrophysiological and biomarker...
First Wave BioPharma Strengthens Intellectual Property Estate
Written by Customer Service on . Posted in Public Companies.
USPTO and WIPO both publish two adrulipase patent applications for composition of matter and methods of use claims involving new enteric formulation and malabsorption indication
BOCA RATON, Fla., June 27, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced the publication of two patent applications for composition of matter and methods of use claims governing the Company’s enhanced enteric microgranule delivery formulation of adrulipase. The two applications were published by both the United States Patent and Trademark Office (USPTO) and the International Bureau of the World International Patent Organization (WIPO)...
GXO Expands Partnership with Abercombie & Fitch to the U.K.
Written by Customer Service on . Posted in Public Companies.
Following successful operations in the U.S., GXO to handle 100% of Abercrombie & Fitch’s ecommerce operations, including returns, in the U.K.
GREENWICH, Conn. and LONDON, U.K., June 27, 2023 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, announced today that it has expanded its partnership with leading global specialty apparel and accessories retailer Abercrombie & Fitch Co. (A&F Co.), managing its ecommerce fulfillment and returns in the U.K. from its dedicated, newly refurbished 170,000-square-foot facility outside London. The expansion follows the success of GXO’s partnership with A&F Co. in the U.S. where the company operates a high-tech distribution centre featuring advanced automation and goods-to-person robotics, intelligent analytics and...